Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Journal of Leukocyte Biology
|
April 7, 2016
Stromal fibroblasts support dendritic cells to maintain IL-23/Th17 responses after exposure to ionizing radiation
Anna Malecka, Qunwei Wang, Sabaria Shah, et al.
International Journal of Cancer
|
March 2, 2012
Synthetic lethal targeting of DNA double-strand break repair deficient cells by human apurinic/apyrimidinic endonuclease inhibitors
Rebeka Sultana, Daniel R McNeill, Rachel Abbotts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2006
Randomized phase II study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinoma
Chooi P Lee, Poulam M Patel, Peter J Selby, et al.
Breast Cancer Research : BCR
|
November 19, 2008
IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines
XingWu Zhu, Lori A Mulcahy, Rabab A A Mohammed, et al.
Cancer Immunology, Immunotherapy : CII
|
November 16, 2023
Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion
Mussarat Wahid, Benjamart Pratoomthai, Isioma U Egbuniwe, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 15, 2011
Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma
Sarah J Storr, Sabreena Safuan, Angana Mitra, et al.
Oncotarget
|
May 17, 2014
Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy
Rachel Abbotts, Rosalyn Jewell, Jérémie Nsengimana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2008
Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survival
Naveen S Vasudev, Janet E Brown, Sarah R Brown, et al.
JHEP Reports : Innovation in Hepatology
|
September 20, 2023
Incidence, risk factors and outcomes of checkpoint inhibitor-induced liver injury: A 10-year real-world retrospective cohort study
Edmond Atallah, Sarah J Welsh, Brent O'Carrigan, et al.
Lancet (London, England)
|
February 16, 2010
Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial
Martin E Gore, Clare L Griffin, Barry Hancock, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Journal of Leukocyte Biology
|
April 7, 2016
Stromal fibroblasts support dendritic cells to maintain IL-23/Th17 responses after exposure to ionizing radiation
Anna Malecka, Qunwei Wang, Sabaria Shah, et al.
International Journal of Cancer
|
March 2, 2012
Synthetic lethal targeting of DNA double-strand break repair deficient cells by human apurinic/apyrimidinic endonuclease inhibitors
Rebeka Sultana, Daniel R McNeill, Rachel Abbotts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2006
Randomized phase II study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinoma
Chooi P Lee, Poulam M Patel, Peter J Selby, et al.
Breast Cancer Research : BCR
|
November 19, 2008
IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines
XingWu Zhu, Lori A Mulcahy, Rabab A A Mohammed, et al.
Cancer Immunology, Immunotherapy : CII
|
November 16, 2023
Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion
Mussarat Wahid, Benjamart Pratoomthai, Isioma U Egbuniwe, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 15, 2011
Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma
Sarah J Storr, Sabreena Safuan, Angana Mitra, et al.
Oncotarget
|
May 17, 2014
Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy
Rachel Abbotts, Rosalyn Jewell, Jérémie Nsengimana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2008
Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survival
Naveen S Vasudev, Janet E Brown, Sarah R Brown, et al.
JHEP Reports : Innovation in Hepatology
|
September 20, 2023
Incidence, risk factors and outcomes of checkpoint inhibitor-induced liver injury: A 10-year real-world retrospective cohort study
Edmond Atallah, Sarah J Welsh, Brent O'Carrigan, et al.
Lancet (London, England)
|
February 16, 2010
Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial
Martin E Gore, Clare L Griffin, Barry Hancock, et al.
Page
of 4